# A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain

> **NCT07225634** · PHASE3 · NOT_YET_RECRUITING · sponsor: **AFT Pharmaceuticals, Ltd.** · enrollment: 60 (estimated)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Combogesic® IV (fixed-dose combination containing acetaminophen 10 mg/ml + ibuprofen 3 mg/ml in 100 ml solution for infusion)

## Key facts

- **NCT ID:** NCT07225634
- **Lead sponsor:** AFT Pharmaceuticals, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225634, "A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Pain". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07225634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*